Amyloid Aggregation of Insulin : An Interaction Study of Green Tea Constituents
Exogenous insulin, used as a therapeutic agent for diabetes, forms insoluble deposits containing amyloid fibrillar structures near the administration site. We have analyzed the in vitro anti-amyloid activity of four green tea constituents: (-)-epigallocatechin gallate (EGCG), (-)-epicatechin (EC), gallic acid (GA), caffeine (CF), and their equimolar mixtures. Regarding individually tested compounds, only EGCG inhibited the fibrillization process. The individual EC, GA, and CF molecules were ineffective. The presence of EGCG in equimolar combinations with GA, EC, or CF was required for the inhibitory activity of most mixtures. Molecular docking revealed that EGCG interacts with an essential amyloidogenic region of insulin chain B. Individually inactive GA had a potentiating effect on the activity of EGCG. In contrast, EC and CF had a negative impact on the activity of the mixtures. We have observed diverse morphology and the amount of insulin amyloid aggregates formed in the presence of studied compounds. The distinct types of amyloid aggregates created in vitro in the presence of EGCG and other green tea constituents were characterized. Results indicate that the biological activity of individual molecules is not directly applicable to the pooled samples effects prediction.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Scientific reports - 10(2020), 1 vom: 04. Juni, Seite 9115 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gancar, Miroslav [VerfasserIn] |
---|
Links: |
---|
Themen: |
3G6A5W338E |
---|
Anmerkungen: |
Date Completed 04.12.2020 Date Revised 04.06.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41598-020-66033-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310791626 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM310791626 | ||
003 | DE-627 | ||
005 | 20231226201519.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41598-020-66033-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n1035.xml |
035 | |a (DE-627)NLM310791626 | ||
035 | |a (NLM)32499589 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gancar, Miroslav |e verfasserin |4 aut | |
245 | 1 | 0 | |a Amyloid Aggregation of Insulin |b An Interaction Study of Green Tea Constituents |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.12.2020 | ||
500 | |a Date Revised 04.06.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Exogenous insulin, used as a therapeutic agent for diabetes, forms insoluble deposits containing amyloid fibrillar structures near the administration site. We have analyzed the in vitro anti-amyloid activity of four green tea constituents: (-)-epigallocatechin gallate (EGCG), (-)-epicatechin (EC), gallic acid (GA), caffeine (CF), and their equimolar mixtures. Regarding individually tested compounds, only EGCG inhibited the fibrillization process. The individual EC, GA, and CF molecules were ineffective. The presence of EGCG in equimolar combinations with GA, EC, or CF was required for the inhibitory activity of most mixtures. Molecular docking revealed that EGCG interacts with an essential amyloidogenic region of insulin chain B. Individually inactive GA had a potentiating effect on the activity of EGCG. In contrast, EC and CF had a negative impact on the activity of the mixtures. We have observed diverse morphology and the amount of insulin amyloid aggregates formed in the presence of studied compounds. The distinct types of amyloid aggregates created in vitro in the presence of EGCG and other green tea constituents were characterized. Results indicate that the biological activity of individual molecules is not directly applicable to the pooled samples effects prediction | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Amyloid |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Protein Aggregates |2 NLM | |
650 | 7 | |a Tea |2 NLM | |
650 | 7 | |a Caffeine |2 NLM | |
650 | 7 | |a 3G6A5W338E |2 NLM | |
650 | 7 | |a Gallic Acid |2 NLM | |
650 | 7 | |a 632XD903SP |2 NLM | |
650 | 7 | |a Catechin |2 NLM | |
650 | 7 | |a 8R1V1STN48 |2 NLM | |
650 | 7 | |a epigallocatechin gallate |2 NLM | |
650 | 7 | |a BQM438CTEL |2 NLM | |
700 | 1 | |a Kurin, Elena |e verfasserin |4 aut | |
700 | 1 | |a Bednarikova, Zuzana |e verfasserin |4 aut | |
700 | 1 | |a Marek, Jozef |e verfasserin |4 aut | |
700 | 1 | |a Mucaji, Pavel |e verfasserin |4 aut | |
700 | 1 | |a Nagy, Milan |e verfasserin |4 aut | |
700 | 1 | |a Gazova, Zuzana |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 10(2020), 1 vom: 04. Juni, Seite 9115 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g number:1 |g day:04 |g month:06 |g pages:9115 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-020-66033-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |e 1 |b 04 |c 06 |h 9115 |